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Summary
Relaxin-3 is a recently identified neuropeptide transmitter primarily expressed by neurons of 
the pontine nucleus incertus, which binds/activates the Gi/o-protein coupled receptor, RXFP3. 
Functional studies have demonstrated that relaxin-3 modulates behavioural arousal in rodents, 
and although initial anatomical mapping studies have revealed relaxin-3-positive projections 
within several brain regions containing neurons that control behavioural arousal, further anal-
ysis of this topography has been hampered by the unavailability of a suitable specific RXFP3 
antibody. In an effort to determine some of the neuron populations that relaxin-3 signalling 
directly modulates, we examined the distribution of relaxin-3 immunoreactive nerve fibres/
terminals within the mouse lateral hypothalamus (LH) and ventrolateral preoptic area (VLPO), 
relative to elements containing protein markers for arousal-related neurons. Within the LH, 
relaxin-3 fibres were predominately distributed more laterally than orexin immunoreactive neu-
rons, in the so-called ‘parvalbumin-immunoreactive’ PV1 region; but direct contacts with these 
parvalbumin neurons were scarce. Within the VLPO, relaxin-3 fibres were observed in close 
contact with galanin-immunoreactive elements, but the soma of the galanin/GABA neurons in 
the area that project to and inhibit arousal-promoting neurons such as orexin/LH cells to pro-
mote sleep, were not identified under the conditions employed. Nonetheless, these preliminary 
studies suggest an interaction between relaxin-3 and VLPO galanin neurons that may contrib-
ute to the arousal-promoting action of relaxin-3. 
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Introduction
Relaxin-3 is a 51 amino acid neuropeptide transmitter that is primarily expressed 
by GABAergic neurons within the pontine nucleus incertus (Ma et al., 2007). The cog-
nate receptor for relaxin-3 is the Gi/o-protein-coupled receptor, RXFP3 (Bathgate et al., 
2006), and several in vitro and in vivo studies indicate that RXFP3 activation likely 
inhibits target neurons, which may act synergistically with co-released GABA. Exist-
ing neuroanatomical and functional evidence suggests a primary role of relaxin-3/
RXFP3 signalling is the modulation of behavioural arousal, which encompasses the 
control of sleep/wake states and other related modalities (Ma et al., 2009; Smith et al., 
2011, 2012).
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The neuroanatomical distribution of relaxin-3 immunoreactive fibres has been 
mapped relative to structural markers within the rat and mouse brain (Ma et al., 
2007; Smith et al., 2010). However, due to the current unavailability of a suitable 
RXFP3 antisera, a need exists to further examine the distribution of relaxin-3 projec-
tions relative to neurochemical markers, in order to more clearly define the targets 
of relaxin-3 action and provide putative neural substrates for the arousal-mediating 
actions of relaxin-3/RXFP3 signalling in rodents (e.g. Olucha-Bordonau et al., 2012). 
The present studies aimed to address this goal, by conducting an initial survey of the 
topography of relaxin-3 fibres relative to neural markers in two arousal-associated 
brain regions of the mouse, the lateral hypothalamus (LH) and the ventrolateral pre-
optic area (VLPO). The LH contains orexin expressing neurons which promote behav-
ioural arousal, wakefulness and feeding (Sakurai, 2007); and neurons that express the 
calcium binding protein, parvalbumin (PV), which notably is expressed by a popula-
tion of glutamatergic neurons in the ‘PV-immunoreactive’ (PV1) region (Meszar et al., 
2012) that contains strong relaxin-3 staining (Smith et al., 2010). The VLPO contains 
sleep-active, GABA/galanin-positive neurons which project to and inhibit the major 
arousal- and wake-promoting neuron populations in the brain (Gaus et al., 2002).
Methods
Brains were harvested from adult, male C57BL/6J mice (n = 3) after transcardi-
al perfusion fixation (4% PFA) and post-fixation for 1 h. Following cryoprotection 
in 20% sucrose overnight, brains were frozen, sectioned (40 um) and subjected to 
standard fluorescence immunohistochemistry (see Ma et al., 2007). Primary antibodies: 
Mouse monoclonal α-relaxin-3 (raw culture media from a cell line provided by the 
International Patent Organism Depositary (IPOD), Japan, 1:5 dilution) (see Tanaka et 
al., 2005); goat α-orexin-A (Santa Cruz Biotechnology, CA, USA, 1:500 dilution); goat 
α-parvalbumin (Swant, Switzerland, 1:2,000 dilution); and rabbit α-galanin (Penin-
sula Laboratories, CA, USA, 1:2,000 dilution). Secondary antibodies: Donkey α-mouse 
DyLight594 and donkey α-rabbit DyLight649 (Jackson Immunoresearch, PA, USA); 
and donkey α-goat Alexa488 (Invitrogen, CA, USA) (all 1:500 dilution). Images were 
obtained by conventional confocal microscopy.
Results
Within the LH, relaxin-3-positive fibres were especially abundant within lateral areas 
– particularly throughout the PV1 region (Fig. 1A), but the identity of the neurons target-
ed by these fibres remains unknown, as only very limited overlap was observed between 
relaxin-3 fibres and PV-positive elements. Relaxin-3 fibres were also distributed laterally 
to orexin-positive neurons/fibres (data not shown), again suggesting very limited, if any, 
direct interactions under basal physiological conditions.
A high density of relaxin-3 immunoreactive fibres was observed within the later-
al preoptic area (LPO; Fig. 1B). At the outer ventral, medial and lateral borders of 
this main plexus of relaxin-3 fibres, an intermingling of galanin-positive fibres was 
observed. Within the VLPO, where a large number of relaxin-3 fibres were observed, 
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Figure 1. A. Low power micrograph of the distribution of relaxin-3 immunoreactive fibres (red) within the parvalbu-
min neuron-positive PV1 region of mouse lateral hypothalamus (LH) (green cells). B. Schematic representation of the 
distribution of relaxin-3 immunoreactive fibres (red lines), galanin immunoreactive fibres (green lines), and the approx-
imate location of close-adjacent galanin and relaxin-3 immunoreactivity (yellow lines) within the preoptic region of the 
mouse brain. The approximate location of sleep-active, galanin-positive neurons within the VLPO, based on literature 
reports (Gaus et al., 2002), is also shown (green dots). High-power confocal micrographs illustrating relaxin-3 (red, C), 
and galanin (green, D) immunoreactivity within the mouse ventrolateral preoptic area (VLPO), with a larger merged 
image shown in (E). F. Summary of putative circuit whereby relaxin-3 (R3)/GABA neurons within the nucleus incertus 
(NI) project to galanin (Gal)/GABA neurons within the VLPO, and to an undefined neuronal population within the PV1 
region of the LH. Direct innervation of orexin (Orx) neurons in the more medial portion of the LH by relaxin-3 fibres may 
be minimal, but VLPO galanin/GABA neurons are known to directly inhibit LH orexin/glutamate (Glu) neurons, which 
can directly activate relaxin-3 neurons in the nucleus incertus. Abbreviations: AVPe, anteroventral periventricular nucle-
us; BSTLV, bed nucleus of the stria terminalis, lateral division, ventral part; HDB, horizontal limb of the diagonal band; 
LPO, lateral preoptic area; MPA, medial preoptic area; MPOC/M, medial preoptic nucleus, central/medial part; opt, optic 
tract; ox, optic chiasm; SI, substantia innominata; VMPO, ventromedial preoptic nucleus. A. Bregma -2.06 mm; B-E. Breg-
ma 0.02 mm. Scale bars (µm): A 100; B 250; C, D 20; E 10.
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these were often adjacent to galanin-positive fibres (Fig. 1C-E). However, there was 
no evidence of galanin-positive cell bodies in the material examined. 
Discussion
These preliminary studies suggest that relaxin-3 neurons innervate galanin-posi-
tive elements associated with galanin neurons within the VLPO. However, in line 
with similar studies that have examined galanin immunoreactivity in non-colchi-
cine-treated mice, only galanin fibres, and not cell bodies, were observed within the 
VLPO (Perez et al., 2001). Colchicine treatment prior to brain perfusion may improve 
the detection of these galanin neurons, but may also reduce the efficiency of detec-
tion of relaxin-3 positive fibres. Alternatively, staining brains from mice following 
disruption of sleep patterns to facilitate increased galanin neuron activity may assist 
their detection. Thereafter confocal and/or electron microscopic analysis of combined 
relaxin-3, synaptic protein and galanin staining should allow confirmation of whether 
these neurons receive a relaxin-3 innervation (see e.g. Olucha-Bordonau et al., 2012). 
If proven, this represents a potentially powerful mechanism through which relax-
in-3 may promote arousal, as a major target of these inhibitory galanin/GABA neu-
rons is the orexin neurons in the LH (Yoshida et al., 2006); and it is possible that 
relaxin-3 promotes arousal by disinhibiting orexin neurons via direct inhibition of 
galanin/GABA VLPO neurons. Preliminary evidence that LH orexin neurons directly 
innervate and activate relaxin-3 neurons (Blasiak et al., 2010), provides further evi-
dence for this putative neural circuit (Fig. 1F).
At present, the identity of RXFP3 expressing neurons within the LH is unknown, 
but resolving this question is of interest, as although little is known about the PV1 
region, strong efferent projections to major arousal centres including the periaque-
ductal grey and dorsal tegmental nucleus have been reported (Meszar et al., 2012), 
and PV1 neurons express other neuropeptides with putative roles in arousal, such as 
PACAP (Girard et al., 2011).
In conclusion, further detailed anatomical studies are required to provide insights 
into the identity of neurons targeted by the broad relaxin-3 innervation of the hypo-
thalamus and other brain areas, in order to reveal the potential mechanisms through 
which relaxin-3 signalling may modulate arousal and behavioural state control.
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